Document is current
Any future updates will be listed below
-
Authors
Aguiar-Ibáñez, Raquel https://orcid.org/0000-0002-3839-6966
Fotheringham, Iain
Mittal, Lalith
Sillah, Arthur
Pathak, Smit
-
Funding
Funding for this research was provided by:
Merck & Co., Inc., Rahway, NJ, USA
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 29 August 2024
First Online: 19 October 2024
Declarations
:
: Raquel Aguiar-Ibáñez is an employee of Merck Canada, Inc., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, the sponsor of this study and corresponding manuscript. Iain Fotheringham, Lalith Mittal, and Smit Pathak are employees of Evidera Inc., a company that received funding from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA to conduct this study. Arthur Sillah was an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, at the time this study was developed, and now is employed at Jazz Pharmaceutical.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
